Our findings indicate that CXCL10 potentially facilitates the progression of pancreatic cancer by modulating the expression of vascular endothelial growth factor A (VEGFA), thereby inducing macrophage polarization towards the M2 phenotype. Here, CXCL10 is linked to familial pancreatic carcinoma.